Rep Profile
Rep Profile
Maureen Mahoney
Company
Mahoney has been with Ortho-McNeil Pharmaceutical Women's Healthcare Division for four years.
Title
Pharmaceutical representative
Current Home
Audobon, PA
Territory: Lehigh Valley, PA, area.
Customers: Obstetricians/gynecologists in offices and hospitals. She also works closely with residents to help them build their practices.
Awards: In 1996, Mahoney was appointed to the company's Leadership Circle, which represents the top eight reps in the company. She was also named District Representative of the Year and Regional Representative of the Year. In 1995, she won the President's Club Award for outstanding sales achievement. In 1994, she was named Rookie of the Year.
Sales springboard: Prior to joining Ortho-McNeil, Mahoney spent three years managing her own company that sold water-purification systems for commercial use.
Sales techniques: "Relationships are the most important reason for my success. I try to build relationships with physicians by helping them add value to their practices with our products or educational programs."
On mentors: "Having a mentor has also helped me achieve success by guiding my direction and focus."
On building sales momentum: "It's easy for me to get up in the morning because I sell products I believe in. It's also easy to stay motivated because I have something new to discuss with physicians: One of our products recently gained a new indication."
The top three qualities a rep needs to succeed: "Tenacity, knowledge and credibility." PR
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.